Friday, September 6, 2013

Study includes fly assays relevant to fragile X-associated tremor ataxia syndrome

Todd PK, Oh SY, Krans A, He F, Sellier C, Frazer M, Renoux AJ, Chen KC, Scaglione KM, Basrur V, Elenitoba-Johnson K, Vonsattel JP, Louis ED, Sutton MA, Taylor JP, Mills RE, Charlet-Berguerand N, Paulson HL. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013 May 8;78(3):440-55. PMID: 23602499.

From the abstract: "In Drosophila, CGG repeat toxicity is suppressed by eliminating RAN translation and enhanced by increased polyglycine protein production. These studies expand the growing list of nucleotide repeat disorders in which RAN translation occurs and provide evidence that RAN translation contributes to neurodegeneration."

Thursday, September 5, 2013

Flies & infection.

Ben-Ami R, Watson CC, Lewis RE, Albert ND, Arias CA, Raad II, Kontoyiannis DP. Drosophila melanogaster as a model to explore the effects of methicillin-resistant Staphylococcus aureus strain type on virulence and response to linezolid treatment. Microb Pathog. 2013 Feb;55:16-20. PMID: 23232438.

Diaz L, Kontoyiannis DP, Panesso D, Albert ND, Singh KV, Tran TT, Munita JM, Murray BE, Arias CA. Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus. J Infect Dis. 2013 Jul;208(1):83-91. PMID: 23547139; PMCID: PMC3666140.


See also this post.

Fly model of Alzheimer's disease is used to explore links to copper homeostasis.

Lang M, Fan Q, Wang L, Zheng Y, Xiao G, Wang X, Wang W, Zhong Y, Zhou B. Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease-like symptoms. Neurobiol Aging. 2013 Nov;34(11):2604-12. PMID: 23827522.

From the abstract:  "These results imply that copper may play a causative role in developing AD ... Early manipulation of brain copper uptake can have a great effect on Aβ pathology."

Fly cells and in vivo assays used in Huntingtons study.

Lu B, Al-Ramahi I, Valencia A, Wang Q, Berenshteyn F, Yang H, Gallego-Flores T, Ichcho S, Lacoste A, Hild M, Difiglia M, Botas J, Palacino J. Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance. Nat Neurosci. 2013 May;16(5):562-70. PMID: 23525043.

New fly model related to neurodegeneration--DRPLA fly model--linking neurodegeneration with autophagy

Charroux B, Fanto M. The fine line between waste disposal and recycling: DRPLA fly models illustrate the importance of completing the autophagy cycle for rescuing neurodegeneration. Autophagy. 2010 Jul;6(5):667-9. PMID: 20543566.

Wednesday, June 26, 2013

High Level Panel Report of Eminent Persons on the Post-2015 Development Agenda Released

 

At the beginning of June, the high level panel (HLP) co-chaired by Prime Minister David Cameron passed its recommendations to the UN secretary-general Ban Ki-moon on the future of the global development agenda.

The report is a hugely ambitious one and has managed to target many of the most pertinent issues in development today and in the future, ranging from food security to economic development and water and sanitation to good governance. It has also crucially included a health specific goal of ensuring healthy lives.

The report has not only built on the millennium development goals (MDGs) but has also looked beyond them up to 2030. For NTDs, this is hugely important.

Great progress has been made in the areas targeted by the MDGs such as malaria and HIV/AIDs with notable successes in both. However, inevitably, those issues that were excluded from the process did suffer in terms of attention and funding, with NTDs a notable example from the health sector.

The Coalition is delighted to note that the report has called for NTDs to be included in the top-level health targets, alongside HIV and AIDS, malaria and tuberculosis. By giving NTDs this platform, we are hopeful that this will help to ensure millions of people can look forward to a future free from the burden that these diseases cause.

Looking ahead, we now await the next stage of this consultative process where the UN General Assembly will make a final decision on what the development agenda will look like beyond 2015 incorporating the sustainable development agenda. The report notes that for all the health goals, the indicators should be further disaggregated and the Coalition urges that this be done with precision, incorporating tangible targets beneath the overarching health goal.


Tuesday, May 28, 2013

NTDs at the World Health Assembly


Members of the UK Coalition against NTDs recently attended the World Health Assembly in Geneva to support the passing of a resolution on neglected tropical diseases. The resolution urges Member States to ensure country ownership of NTD programmes and supports an integrated approache to achieve the World Health Organisation NTD roadmap targets.

Read our statement to the World Health Assembly (presented by Sightsavers):

"Thank you, Chair, for the opportunity to address the World Health Assembly on behalf of Sightsavers who currently Chair the UK Coalition against neglected tropical diseases. We are pleased to share our support for this resolution and its recognition of the importance of NTDs to global health.

We welcome Dr Chan’s support for NTDs. This leadership is essential and needed more than ever to reach our ambitious control, elimination and eradication targets by 2020. WHO recognition that increased investment in NTDs has improved health and social well-being in many countries is valued- and we commend the political will that this resolution demonstrates.

This resolution represents a transformative milestone, continuing the positive momentum generated by the London Declaration and the WHO Road Map. We applaud the recognition that NTDs represent a major global health priority and that partnership, collaboration and integration must form the bedrock of the drive to end NTDs. This partnership must include endemic country governments, NGOs, donors and pharmaceutical companies.  

We look to WHO member states to lead the charge and ensure that the resolution’s implementation realises the need for cross-sectoral collaboration across planning, programme implementation monitoring and evaluation. Endemic countries must be supported to implement NTD programmes in an integrated, community-led way, targeting the poorest and most marginalised populations and delivering sustainable, lasting change.

The elimination of NTDs rests on consistent action to tackle their structural determinants. In particular, water, sanitation and hygiene (WASH) services represent a major safeguard against many of the NTDs and should be promoted and supported as part of a cross-sectoral commitment to reaching the WHO’s 2020 targets.

We encourage endemic country Member States to bring together all relevant NTD stakeholders including health, water and education actors to drive forward cross-sectoral action.  NTD implementation plans must be aligned with wider health systems based on primary health care with strong community participation and cross-sectoral collaboration if they are to be sustainable.

As partners actively engaged in the implementation, capacity building and research of NTDs, the UK Coalition will continue to support a cross-sectoral approach- championing efforts to develop the diversity and breadth of stakeholders involved in NTDs.

NTDs are diseases of poverty; afflicting those who are subject to low access to water and sanitation services, poor or limited access to health care and overcrowded living conditions. NTD control and elimination will contribute to increased education outcomes, economic productivity and it will reduce social inequalities in health within and between countries. We have the tools and the knowledge of what needs to be done to end the suffering caused by NTDs. However our ambition to end these"